Bay Area AI Startups See Surge in Series B Funding
Several Bay Area AI startups have announced significant funding rounds, signaling strong investor confidence. Uptiq raised $25 million for enterprise AI, Simile emerged from stealth with $100 million for behavioral prediction, and OPAQUE landed $24 million for privacy-focused AI. Additionally, Electric Twin closed a $14 million round to expand its AI audience platform.
- OPAQUE's technology for "confidential AI" originated from UC Berkeley's RISELab and provides cryptographic proof that a company's data and AI models remain private during use. The recent funding brings the company's total to $55.5 million and included strategic investments from Intel Capital and the Advanced Technology Research Council (ATRC). - Simile's AI agents are trained on a combination of real-life interviews, historical transaction data, and text from behavioral science journals to simulate and predict consumer choices. Co-founder Michael Bernstein was previously a co-author of the influential ImageNet project, a key benchmark in computer vision technology. - Electric Twin was founded by Dr. Ben Warner and Alex Cooper, two former senior advisors to the UK Prime Minister who worked on data and crisis response. The company's platform creates "synthetic audiences" by combining real-world survey data with large language models to test how people will react to new products or messaging. - Uptiq will use a significant portion of its new capital to scale its AI research and engineering hub in Pune, India, which serves as its global center for financial AI development. The company's platform is already used by over 140 financial institutions and has processed more than $1 billion in transactions. - The investment in Electric Twin included notable angel investors such as Marc Andreessen (co-founder of Andreessen Horowitz) and Cal Henderson (co-founder of Slack). - Simile's funding round was led by Index Ventures and included participation from prominent AI researchers Fei-Fei Li and Andrej Karpathy. The company has already tested its technology with clients like CVS Health Corp. to help decide which items to stock in stores. - While these Series B rounds show strong investor interest, the broader Bay Area AI funding environment in early 2026 has seen a year-over-year drop in the number of deals and total funding compared to early 2025. Investors are becoming more selective, demanding clearer paths to revenue and defensible, proprietary data.
